(BLKB) Blackbaud - Overview
Stock: Fundraising, Financial, Grant, Education, Payment
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 44.0% |
| Relative Tail Risk | -8.01% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.41 |
| Alpha | -50.51 |
| Character TTM | |
|---|---|
| Beta | 0.575 |
| Beta Downside | 0.325 |
| Drawdowns 3y | |
|---|---|
| Max DD | 47.25% |
| CAGR/Max DD | -0.17 |
Description: BLKB Blackbaud January 11, 2026
Blackbaud, Inc. (NASDAQ:BLKB) delivers a suite of cloud-based software and services aimed at nonprofit and educational institutions worldwide. Its portfolio spans fundraising and engagement platforms (e.g., Raisers Edge NXT, Blackbaud CRM, JustGiving), financial management tools (e.g., Financial Edge NXT, Tuition Management), grant and award administration, education management systems, corporate social responsibility solutions (YourCause), and payment processing through Blackbaud Merchant Services. The company also offers data-intelligence, professional services, and training, selling primarily via a direct sales force.
Key recent metrics show FY 2025 revenue of roughly $1.2 billion, a 7 % YoY increase driven by higher subscription renewals and expansion in the education segment. ARR (annual recurring revenue) grew 9 % year-over-year, while net churn remained low at 2 %, reflecting strong customer stickiness in the nonprofit SaaS market. The sector benefits from rising charitable giving-projected to exceed $500 billion in the U.S.-and increasing digital transformation budgets among schools and NGOs, both of which underpin Blackbaud’s growth outlook.
For a deeper dive into BLKB’s valuation and comparative metrics, you might explore ValueRay’s analyst tools.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: -252.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 5.35 > 1.0 |
| NWC/Revenue: -25.59% < 20% (prev -26.71%; Δ 1.12% < -1%) |
| CFO/TA 0.13 > 3% & CFO 281.1m > Net Income -252.4m |
| Net Debt (1.03b) to EBITDA (17.08b): 0.06 < 3 |
| Current Ratio: 0.69 > 1.5 & < 3 |
| Outstanding Shares: last quarter (48.5m) vs 12m ago -6.07% < -2% |
| Gross Margin: 57.75% > 18% (prev 0.55%; Δ 5720 % > 0.5%) |
| Asset Turnover: 48.26% > 50% (prev 44.14%; Δ 4.12% > 0%) |
| Interest Coverage Ratio: 1.01 > 6 (EBITDA TTM 17.08b / Interest Expense TTM 16.82b) |
Altman Z'' 10.00
| A: -0.14 (Total Current Assets 638.8m - Total Current Liabilities 929.4m) / Total Assets 2.10b |
| B: -0.01 (Retained Earnings -21.2m / Total Assets 2.10b) |
| C: 7.22 (EBIT TTM 16.98b / Avg Total Assets 2.35b) |
| D: -0.02 (Book Value of Equity -30.3m / Total Liabilities 2.00b) |
| Altman-Z'' Score: 47.55 = AAA |
Beneish M -3.52
| DSRI: 0.83 (Receivables 86.6m/105.3m, Revenue 1.14b/1.15b) |
| GMI: 0.95 (GM 57.75% / 55.06%) |
| AQI: 0.93 (AQ_t 0.65 / AQ_t-1 0.70) |
| SGI: 0.99 (Revenue 1.14b / 1.15b) |
| TATA: -0.25 (NI -252.4m - CFO 281.1m) / TA 2.10b) |
| Beneish M-Score: -3.52 (Cap -4..+1) = AAA |
What is the price of BLKB shares?
Over the past week, the price has changed by -9.32%, over one month by -23.22%, over three months by -19.18% and over the past year by -40.47%.
Is BLKB a buy, sell or hold?
- StrongBuy: 0
- Buy: 2
- Hold: 3
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the BLKB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 76.4 | 60.9% |
| Analysts Target Price | 76.4 | 60.9% |
| ValueRay Target Price | 45.8 | -3.5% |
BLKB Fundamental Data Overview February 03, 2026
P/S = 2.2929
P/B = 23.7338
P/EG = 0.1193
Revenue TTM = 1.14b USD
EBIT TTM = 16.98b USD
EBITDA TTM = 17.08b USD
Long Term Debt = 1.04b USD (from longTermDebt, last quarter)
Short Term Debt = 24.2m USD (from shortTermDebt, last quarter)
Debt = 1.07b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.03b USD (from netDebt column, last quarter)
Enterprise Value = 3.64b USD (2.60b + Debt 1.07b - CCE 38.3m)
Interest Coverage Ratio = 1.01 (Ebit TTM 16.98b / Interest Expense TTM 16.82b)
EV/FCF = 13.92x (Enterprise Value 3.64b / FCF TTM 261.3m)
FCF Yield = 7.18% (FCF TTM 261.3m / Enterprise Value 3.64b)
FCF Margin = 23.01% (FCF TTM 261.3m / Revenue TTM 1.14b)
Net Margin = -22.23% (Net Income TTM -252.4m / Revenue TTM 1.14b)
Gross Margin = 57.75% ((Revenue TTM 1.14b - Cost of Revenue TTM 479.7m) / Revenue TTM)
Gross Margin QoQ = 59.57% (prev 59.72%)
Tobins Q-Ratio = 1.73 (Enterprise Value 3.64b / Total Assets 2.10b)
Interest Expense / Debt = 1566 % (Interest Expense 16.77b / Debt 1.07b)
Taxrate = 21.0% (US default 21%)
NOPAT = 13.42b (EBIT 16.98b * (1 - 21.00%))
Current Ratio = 0.69 (Total Current Assets 638.8m / Total Current Liabilities 929.4m)
Debt / Equity = 9.90 (Debt 1.07b / totalStockholderEquity, last quarter 108.2m)
Debt / EBITDA = 0.06 (Net Debt 1.03b / EBITDA 17.08b)
Debt / FCF = 3.95 (Net Debt 1.03b / FCF TTM 261.3m)
Total Stockholder Equity = 92.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -10.73% (Net Income -252.4m / Total Assets 2.10b)
RoE = -271.9% (Net Income TTM -252.4m / Total Stockholder Equity 92.8m)
RoCE = 1497 % (out of range, set to none) (EBIT 16.98b / Capital Employed (Equity 92.8m + L.T.Debt 1.04b))
RoIC = 1101 % (out of range, set to none) (NOPAT 13.42b / Invested Capital 1.22b)
WACC = 5.69% (E(2.60b)/V(3.68b) * Re(8.03%) + (debt cost/tax rate unavailable))
Discount Rate = 8.03% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.61%
[DCF Debug] Terminal Value 87.02% ; FCFF base≈230.3m ; Y1≈247.4m ; Y5≈302.2m
Fair Price DCF = 165.4 (EV 8.94b - Net Debt 1.03b = Equity 7.91b / Shares 47.8m; r=5.90% [WACC]; 5y FCF grow 8.33% → 2.90% )
EPS Correlation: 8.29 | EPS CAGR: -40.20% | SUE: -4.0 | # QB: 0
Revenue Correlation: 74.02 | Revenue CAGR: 3.41% | SUE: 0.50 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.10 | Chg30d=-0.087 | Revisions Net=+1 | Analysts=4
EPS next Year (2026-12-31): EPS=4.87 | Chg30d=-0.063 | Revisions Net=+1 | Growth EPS=+10.3% | Growth Revenue=+4.2%